Fresenius medical care achieves next milestone in portfolio optimization program, announcing sale of dialysis clinics in brazil, colombia, chile, ecuador

Divestment of assets includes four separate country transactions to davita inc. for usd 300 million transactions further reduce the company`s clinic footprint in latin america, following the exit from argentina at the end of 2023 expected to close throughout 2024 proceeds to be used to reduce debt bad homburg, germany , march 5, 2024 /prnewswire/ -- fresenius medical care, the world's leading provider of products and services for individuals with renal diseases, today announced the sale of its dialysis clinic networks in brazil, colombia, chile and ecuador to davita inc. for a total transaction price of usd 300 million. subject to regulatory approvals in brazil, colombia and ecuador, the transactions represent another milestone in fresenius medical care's portfolio optimization program, with each expected to close throughout 2024.
FMS Ratings Summary
FMS Quant Ranking